Malnick Stephen D H, Zimhony Oren
Department of Internal Medicine C, Kaplan Medical Center, Rehovot, Israel.
Ann Pharmacother. 2002 Nov;36(11):1767-75. doi: 10.1345/aph.1A160.
To review the literature related to the treatment and infection control of Clostridium difficile-associated diarrhea (CDAD).
A MEDLINE search (1966-August 2001) of the English literature was conducted.
C. difficile is a leading cause of antibiotic-related diarrhea. The clinical spectrum extends from simple diarrhea to fulminant colitis. Cessation of antibiotic therapy alone is sufficient for mild cases; however, the majority of cases require oral metronidazole as the drug of choice. Vancomycin orally is reserved for patients who have failed to respond to metronidazole, are pregnant, or are severely ill. There is an important role for infection control interventions.
CDAD is a common infection. Appropriate antibiotic treatment and infection control policies can prevent the spread and reduce the morbidity associated with this disease.
回顾与艰难梭菌相关性腹泻(CDAD)治疗及感染控制相关的文献。
对1966年至2001年8月的英文文献进行了MEDLINE检索。
艰难梭菌是抗生素相关性腹泻的主要病因。临床谱从单纯腹泻到暴发性结肠炎。仅停用抗生素治疗对轻症病例就足够了;然而,大多数病例需要口服甲硝唑作为首选药物。口服万古霉素适用于对甲硝唑无反应、怀孕或病情严重的患者。感染控制干预措施具有重要作用。
CDAD是一种常见感染。适当的抗生素治疗和感染控制政策可预防其传播并降低与该疾病相关的发病率。